Equities

Precision BioSciences Inc

Precision BioSciences Inc

Actions
  • Price (EUR)8.35
  • Today's Change-0.300 / -3.47%
  • Shares traded70.00
  • 1 Year change-28.26%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments117190144
Total Receivables, Net130.720.49
Total Inventory------
Prepaid expenses5.987.5517
Other current assets, total0.911.260.17
Total current assets136199162
Property, plant & equipment, net152329
Goodwill, net------
Intangibles, net0.401.352.05
Long term investments3.214.756.84
Note receivable - long term4.997.236.88
Other long term assets0.232.574.64
Total assets160238211
LIABILITIES
Accounts payable2.971.231.14
Accrued expenses7.671213
Notes payable/short-term debt2200
Current portion long-term debt/capital leases------
Other current liabilities, total174722
Total current liabilities506036
Total long term debt0222.48
Total debt22222.48
Deferred income tax------
Minority interest------
Other liabilities, total919682
Total liabilities141178120
SHAREHOLDERS EQUITY
Common stock0.000.000.00
Additional paid-in capital509490409
Retained earnings (accumulated deficit)(490)(428)(317)
Treasury stock - common(0.95)(0.95)(0.95)
Unrealized gain (loss)------
Other equity, total----0.00
Total equity196091
Total liabilities & shareholders' equity160238211
Total common shares outstanding4.163.702.03
Treasury shares - common primary issue0.030.030.03
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.